- Home
- PGRE vs BCRX Comparison
PGRE vs BCRX Comparison
Compare PGRE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGRE
- BCRX
- Stock Information
- Founded
- PGRE 1978
- BCRX 1986
- Country
- PGRE United States
- BCRX United States
- Employees
- PGRE N/A
- BCRX N/A
- Industry
- PGRE Real Estate Investment Trusts
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PGRE Real Estate
- BCRX Health Care
- Exchange
- PGRE Nasdaq
- BCRX Nasdaq
- Market Cap
- PGRE 1.4B
- BCRX 1.4B
- IPO Year
- PGRE 2014
- BCRX 1994
- Fundamental
- Price
- PGRE $6.56
- BCRX $6.84
- Analyst Decision
- PGRE Hold
- BCRX Strong Buy
- Analyst Count
- PGRE 5
- BCRX 11
- Target Price
- PGRE $6.80
- BCRX $19.55
- AVG Volume (30 Days)
- PGRE 2.3M
- BCRX 7.3M
- Earning Date
- PGRE 10-29-2025
- BCRX 11-03-2025
- Dividend Yield
- PGRE N/A
- BCRX N/A
- EPS Growth
- PGRE N/A
- BCRX N/A
- EPS
- PGRE N/A
- BCRX N/A
- Revenue
- PGRE $681,644,000.00
- BCRX $599,816,000.00
- Revenue This Year
- PGRE $1.41
- BCRX $41.57
- Revenue Next Year
- PGRE N/A
- BCRX $6.25
- P/E Ratio
- PGRE N/A
- BCRX N/A
- Revenue Growth
- PGRE 23.12
- BCRX 45.38
- 52 Week Low
- PGRE $3.75
- BCRX $6.00
- 52 Week High
- PGRE $7.85
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- PGRE 47.84
- BCRX 39.58
- Support Level
- PGRE $6.51
- BCRX $6.44
- Resistance Level
- PGRE $6.56
- BCRX $7.47
- Average True Range (ATR)
- PGRE 0.02
- BCRX 0.26
- MACD
- PGRE 0.01
- BCRX 0.05
- Stochastic Oscillator
- PGRE 100.00
- BCRX 38.83
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.